Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-23T18:53:53.207Z Has data issue: false hasContentIssue false
  • English
  • Français

Good practice in attention deficit hyperactivity disorder

Published online by Cambridge University Press:  13 June 2014

Fiona McNicholas
Fiona McNicholas*
Affiliation:
Department of Child Psychiatry, Columbia University, Unit 74, 1051 Riverside Drive, New York 10032, US
Get access Rights & Permissions [Opens in a new window]

Abstract

Major advances have been made in ADHD over the years, both in terms of diagnostic validity, different subtypes, comorbidities and treatment options. A comprehensive assessment needs to include medical, developmental and educational history using multiple sources of information and across different settings. In certain cases, additional investigations and neuropsychological testing may need to complement basic physical and neurological examination. The focus of treatment must include not only the core ADHD symptoms but also additional comorbid problems, family and peer relationships, and academic achievement. Treatment should therefore be multi-modal with simultaneous medication, behavioural and educational management. Both diagnosis and treatment response needs to be reviewed regularly to ensure optimal response with minimal adverse side effects.

The increased awareness of ADHD by both clinicians and other professionals has resulted in a huge increase of referrals for assessment, diagnosis and treatment. In particular, families are becoming increasingly knowledgeable about the disorder and are rightly requesting adequate assessment and treatment of their children. It is therefore essential that all clinicians are equally knowledgeable about the advances in this area and offer a service to families which represents good clinical practice. This article reviews what constitutes good clinical practice in ADHD.

Keywords

ADHDAssessmentDiagnosisTreatmentGood clinical practiceStandards.
Type
Review
Information
Irish Journal of Psychological Medicine , Volume 17 , Issue 2 , June 2000 , pp. 62 - 66
Copyright
Copyright © Cambridge University Press 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Cantwell, DP. Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996; 35(8): 978–87.CrossRefGoogle ScholarPubMed
2.Swanson, J, Lerner, M, Williams, L. More frequent diagnosis of attention deficit hyperactivity disorder (letter). N Engl J Med 1995; 333: 944.CrossRefGoogle Scholar
3.Taylor, EA, Sandberg, ST. Hyperactive behaviour in English schoolchildren: a questionnaire survey. J Abn Psychol 1984; 12: 143–56.CrossRefGoogle ScholarPubMed
4.Taylor, E, Sergeant, J, Doepfner, M, Gunning, B, Overmeyer, S, Mobius, HJ, Eisert, HG. European clinical guidelines for hyperkinetic disorder. European Child Adolescent Psychiat 1998; 7: 184–200.CrossRefGoogle ScholarPubMed
5.Ladd, ET. Pills for classroom peace. Saturday Review 1970 (November 21); 66–8.Google Scholar
6.Rogers, JM. Drug abuse – just what the doctor ordered. Psychology Today 1971 (September); 16–24.Google Scholar
7.Schmidt, WE. Sales of drugs are soaring for treatment of hyperactivity. The New York Times C-2. 1988, April 1.Google Scholar
8.Greenhill, L. Attention deficit hyperactivity disorder. In: Walsh, BT (ed). Child Psychopharmacology. Review of Psychiatry. American Psychiatric Press Inc. Vol 17.Google Scholar
9.Safer, DJ, Krager, JM. A survey of medication treatment for hyperactive/inattentive students. JAMA 1988; 260: 2256–8.CrossRefGoogle ScholarPubMed
10.Attention deficit disorder in Ireland. Oireachtas Committee on Health and Children. Report compiled bv the National Research Agency Ltd. January 1999.Google Scholar
11.Jensen, PS, Kettle, L, Roper, MT, Sloan, MT, Dulcan, MK, Hover, C, Bird, HR, Bavermeister, JJ, Pavne, JD. Are stimulants overprescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiat 1999; 38: 797–804.CrossRefGoogle ScholarPubMed
12.Wolraich, Hannah, JN, Pinnock, TY, Baumgaerel, A, Brown, J. Comparison of diagnostic criteria for attention deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiat 1996; 35: 319–24.CrossRefGoogle Scholar
13.Szatmari, P, Offord, DR, Boyle, HH. Correlates, associated impairments and patterns of service utilisation of children with attention deficit disorder: Findings from the Ontano Child Health Study. J Child Psychol Psych 1989; 30: 205–17.CrossRefGoogle Scholar
14.Nottlemann, E, Jensen, P. Comorbidity of disorders in children and adolescents: developmental perspectives. In: Advances in Clinical Child Psychology. New York, Plenum 1995; 17: 109–55.CrossRefGoogle Scholar
15.Cantwell, DP. Hyperactive children have grown up. What have we learned about what happened to them? Arch Gen Psych 1985; 42:1026–28.CrossRefGoogle Scholar
16.Cantwell, DP. Therapeutic Management of Attention Deficit Disorder: Participant Workbook. New York SCP Communication 1994; 4–20.Google Scholar
17.Steere, G, Arnsten, AFT. Corpus callosum morphology in ADHD. Am J Psychiat 1995; 152; 1105–07.Google ScholarPubMed
18.Castellanos, FX, Giedd, JN, Eckburg, P. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiat 1994; 151:1791–6.Google ScholarPubMed
19.La Hoste, GJ, Swanson, JM, Wigal, SB, Glabe, C, Wigal, T, King, N, Kennedy, JL. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiat 1996; 1: 121–4.Google ScholarPubMed
20.Gill, M, Daly, G, Heron, S, Havvi, Z, Fitzgerald, M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Molecular Psychiat 1997; 2 311–3.CrossRefGoogle Scholar
21.Cook, EH, Stein, MA, Krasowski, MD, Cox, NJ, Olkon, DM, Kieffer, JE, Leventhal, BL. Association of attention deficit hyperactivity disorder and the dopamine transporter gene. Am J Human Genetics 1995; 56: 993–8.Google ScholarPubMed
22.Spencer, T, Biederman, J, Wilens, Tet al.Pharmacotherapy of attention deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiat 1996; 35: 409–32.CrossRefGoogle ScholarPubMed
23.Dulcan, M, Benson, RS. Summary of the practice parameters for the assessment and treatment of children, adolescents and adults with ADHD. J Am Acad Child Adolesc Psychiat 1997; 36: 91311–7.CrossRefGoogle ScholarPubMed
24.Gringras, P, McNicholas, F. Developing rational protocols for paediatric psychopharmacological prescribing. Child: Care Health Devel 1999; 25(3): 223–33.CrossRefGoogle ScholarPubMed
25.Conners, K. Conners Abbreviated Symptom Questionnaire North Tonawanda. NY: Multi Health Systems, 1994.Google Scholar
26.Evans, SW, Pelham, WE. Psychostimulant effects on academic and behavioural measures for ADHD junior high school students in a lecture format classroom. J Ab Child Psychol 1991; 19: 537–52.CrossRefGoogle Scholar
27.Swanson, JM, Cantwell, DP, Lerner, M, Hanna, GL. Effects of stimulant medication on learning in children with ADHD. J Learning Disabilities 1991; 4:219-30, 255.Google Scholar
28.Schachar, R, Taylor, E, Wieselberg, M, Thorley, G, Rutter, M. Changes in family function and relationship in children who respond to methylphenidate. J Am Acad Child Adolesc Psychiat 1987; 26: 728–32.CrossRefGoogle ScholarPubMed
29.MTA Co-operative group. A 14 month randomised clinical trial of treatment strategies for attention deficit/hyperactivity disorder. Arch Gen Psychiat 1999; 56: 1073–1086CrossRefGoogle Scholar
30.MTA Co-operative group, moderators and mediators of treatment response for children with attention deficit/hvperactivity disorder. Arch Gen Psychiat 1999;56:1088–96.CrossRefGoogle Scholar
31.Greenhill, L, Abikoff, H, Arnold, E, Cantwell, DP, Conners, K, Elliott, G, Hechrman, L, Hinshaw, SP, Hoza, B, Jensen, PS, March, JB, Swanson, JM, Vitiello, B, Wells, K. Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiat 1996; 35(10): 1305–13.CrossRefGoogle ScholarPubMed
32.Lambert, NM, Hartsbough, CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. Journal of Learning Disabilities 1998; 31(6): 533–44.CrossRefGoogle ScholarPubMed
33.Biederman, J, Wilens, T, Mick, E, Spencer, T, Farone, SV. Pharmacotherapy of attention deficit/hvperactivitv disorder reduces risk for substance use disorder. Pediatrics 1999; 104(2): 293–4.CrossRefGoogle ScholarPubMed
34.Fitzgerald, M, Adult attention deficit hyperactivity disorder. Ir J Psych Med 1998; 15(3): 82–3.CrossRefGoogle Scholar